Net Cash Provided by (Used in) Operating Activities |
-487 K |
USD |
-57.1% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-4 K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-375 K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-866 K |
USD |
-180% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
641 K |
USD |
+12.9% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
323 K |
USD |
+353% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
323 K |
USD |
+353% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
-250 K |
USD |
-243% |
Dec 31, 2023 |
2023 |
Preferred Stock, Shares Authorized |
1 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
0 |
USD |
|
Jun 30, 2023 |
Q2 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
796 K |
USD |
+488% |
Dec 31, 2023 |
2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |